Targeting CDK4/6 in Cancer: Molecular Docking and Cytotoxic Evaluation of <i>Thottea siliquosa</i> Root Extract
<b>Background</b>: Cyclin-dependent kinases 4 and 6 (CDK4/6) are pivotal regulators of the cell cycle, whose dysregulation is closely linked to cancer progression. While synthetic CDK4/6 inhibitors such as Palbociclib and Ribociclib are clinically effective, their use is limited by signi...
Saved in:
| Main Authors: | Maruthamuthu Rathinam Elakkiya, Mohandas Krishnasreya, Sureshkumar Tharani, Muthukrishnan Arun, L. Vijayalakshmi, Jiseok Lim, Ayman A. Ghfar, Balasundaramsaraswathy Chithradevi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/7/1658 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamic Mitotic Localization of the Centrosomal Kinases CDK1, Plk, AurK, and Nek2 in <i>Dictyostelium amoebae</i>
by: Stefan Krüger, et al.
Published: (2024-09-01) -
Design, Synthesis and Molecular Modeling of Pyrazolo[1,5-<i>a</i>]pyrimidine Derivatives as Dual Inhibitors of CDK2 and TRKA Kinases with Antiproliferative Activity
by: Mohamed H. Attia, et al.
Published: (2024-12-01) -
Synthesis, ADME, and In Silico Molecular Docking Study of Novel N-Substituted <i>β</i>-Carboline Analogs as a Potential Anticancer Agent
by: Sunil Gaikwad
Published: (2024-11-01) -
Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancer
by: Paola Zagami, et al.
Published: (2025-02-01) -
Development of CDK4/6 Inhibitors in Gastrointestinal Cancers: Biomarkers to Move Forward
by: Ioannis A. Voutsadakis
Published: (2025-06-01)